ABSTRACT The metallothionein gene is transcriptionally regulated by zinc. Consequently, metallothionein has potential for serving as an index of dietary zinc status in humans. To examine this possibility, an enzyme-linked immunoassay (ELISA) based on a sandwich approach that utilizes monoclonal and chicken egg yolk antibodies was used to compare the response of erythrocyte metallothionein protein levels with the response of monocyte metallothionein mRNA levels as measured by competitive reverse transcriptase-polymerase chain reaction (CRT-PCR) during zinc supplementation. Young male subjects participated in an 18-d supplementation study in which zinc was provided at 50 mg/d. Control subjects received a placebo. The zinc supplement resulted in significantly greater erythrocyte metallothionein levels by d 8 of supplementation compared with controls. Monocyte metallothionein mRNA levels were significantly greater than those of controls by d 2 of supplementation. Both remained elevated through d 18. They returned to base line by 8 and 4 d after supplementation, respectively. The plasma zinc concentration was significantly greater than in controls by d 6 and had returned to control levels by d 22 of supplementation. The results presented here show that both monocyte metallothionein mRNA and erythrocyte metallothionein protein concentrations change in human subjects in response to elevated dietary zinc intake and that monocyte metallothionein mRNA responds more rapidly to elevation of dietary zinc status than erythrocyte metallothionein protein. Consequently, both erythrocyte metallothionein and monocyte metallothionein mRNA may prove to be measures useful for assessment of either zinc depletion or the bioavailability of zinc supplements. J. Nutr. 128: 707-713, 1998. 
The assessment of nutritional status usually is based on is achieved through a variety of zinc transporters and intraceleither the level of the nutrient in a blood component or a lular binding proteins that regulate absorption and cellular zinc measurable variable associated with a function that responds influx and efflux. In contrast, a variety of mediators, including to dietary intake and/or body stores of that nutrient. Zinc endotoxin and interleukin 1, act to redistribute zinc to specific status assessment has presented a particular challenge. Meatissues by a process that involves metallothionein (MT) 6 synsurement of zinc levels in plasma or blood cells, although thesis and most likely the activities of various cellular zinc technically straightforward with the use of atomic absorption transporters (reviewed in Cousins 1996 , King 1990 , Mills spectrophotometric methods, does not appear to be a reliable 1989). and sensitive predictor of zinc status. The plasma zinc concenFunctions of zinc can be categorized as catalytic (metalloentration is homeostatically regulated at 10-15 mmol/L. There zymes), structural (e.g., zinc finger domains of proteins) and appears to be an adaptation to low zinc intake that decreases regulatory (e.g., metal response elements of gene promoters) zinc excretion to achieve a conservation of this micronutrient (Cousins 1996) . Regulation of the metallothionein gene reand maintenance of a normal plasma zinc concentration. This flects this latter function. Metallothionein expression has been shown in numerous animal and cell experiments to be regulated by zinc and some other metals (Cousins 1994, Dunn et 1992, Sato et al. 1984) .
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The homogenate was centrifuged at 40,000 1 g for 10 min at 4ЊC.
of the longitudinal zinc supplementation study reported here
The supernatant was heated in a 100ЊC water bath for 5 min and demonstrate that monocyte metallothionein mRNA levels in- oped sandwich ELISA for human metallothionein is described plete Freund's adjuvant at 2-wk intervals. Eggs were collected and yolk immunoglobulin G (IgY) was isolated using a method adapted from Gassman et al. (1990) and Hassl and Aspôck (1988) . Each
SUBJECTS AND METHODS
separated yolk was mixed with polyethylene glycol (5.5 mmol/L) solution. The supernatant (3600 1 g for 1 h) was placed on a SephaSubjects and experimental design. Twenty-five male subjects berose CL4B (Pharmacia) hydrophobic interaction column. The IgY tween the ages of 19 and 35 y (mean Å 24 y) with a mean weight was eluted with dd H 2 O, pooled and concentrated by ultrafiltration. of 72 kg were selected from volunteers. The study was approved by Protein fractions were identified by measuring absorbance at 280 nm. the Institutional Review Board of the University of Florida. Written
The chicken IgY fraction was biotinylated with the use of a Protein informed consent was obtained from each subject before any tests or Biotinylation System (Gibco BRL). The molar ratio of biotin to IgY other participation took place. After an initial screening interview, averaged 30:1. subjects who consumed a typical nonvegetarian diet and had normal Monoclonal antibodies. A monoclonal antibody specific for meblood chemistry profiles (SMAC 25; SmithKline Beecham, Coltallothionein was developed. Lypholized, purified human metallothiolegeville, PA) were used. All subjects agreed to refrain from drinking nein-1 was diluted in 100 mmol/L 2-(N-morpholino)ethanesulfonic alcohol, to avoid eating specific zinc-rich foods (such as oysters and acid and 150 mmol/L NaCl, pH 4.7. 1-Ethyl-3-(3-dimethylaminoproother shellfish), to consume no mineral or vitamin supplements, to pyl)carbodiimide (EDC) was then added to form a metallothionein/ limit their intake of caffeine and to disclose any illness that developed EDC conjugate with keyhole limpet hemocyanin (KLH) as described during their participation.
by the manufacturer (Pierce, Rockford, IL). Balb C mice were immuThe 36-d study was divided into three phases. The first phase was nized with the metallothionein/KLH conjugate in complete Freund's a 7-d acclimation phase (from d 07 to d 0). For the zinc supplementaadjuvant for the initial injection. Incomplete Freund's adjuvant was tion phase (d 1-18), subjects were randomly divided into either a used for injections over a 5-mo period. Mice with the highest titers treatment group that received 50 mg of zinc (as zinc gluconate) per were then killed for spleen B lymphocyte-myeloma cell fusions. A day or a control group that received 50 mg sodium carbonate per hybridoma clone that cross-reacted with both metallothionein-1 and day. Zinc supplementation was before the morning meal and was -2 was selected and cultured in Dulbecco's modified Eagle's medium. under supervision to ensure compliance. During the postsupplementa-
The murine IgG was purified using Protein G Sepharose 4 fast flow tion phase, subjects received no supplement or placebo for 12 d (d 19-30). All blood samples were drawn after an overnight fast between (Pharmacia) chromatography before use.
Protein quantitation. Protein measurements for erythrocyte lysate, metallothionein and antibody concentrations were made by the method of Lowry et al. (1951) with the use of a BSA standard. Because sulfhydryl groups interfere with the Lowry assay, a correction factor was used for all metallothionein measurements (Grider et al. 1989) .
Statistical analysis. Linear regression (Excel 4.0 software; Microsoft, Redmond, WA) was used to determine concentrations for monocyte metallothionein cDNA, erythrocyte metallothionein and plasma zinc. Tests for significance were performed by repeated measures AN-OVA using mixed model methodology (Littell et al. 1996 , SAS Institute 1985 . Significance was established at P õ 0.05.
RESULTS

Erythrocyte metallothionein.
A variety of antibodies generated in our laboratory and some commercially available antibodies were tested in developing the sandwich ELISA. These included polyclonal sheep anti-metallothionein IgG (Grider et al. 1989 ) used previously, the chicken anti-human metallothionein IgY (described above), commercially available mouse monoclonal anti-metallothionein antibody and the monoclonal IgG described above. After considerable evaluation, a monoclonal anti-human metallothionein IgG, produced as we described above, that exhibited uniform cross-reactivity to cyte lysates (data not shown). A standard curve for human NaN 3 ). Purified metallothionein or erythrocyte lysate (100 mL) was added. Plates were washed and biotinylated chicken anti-human memetallothionein is shown in Figure 3. tallothionein IgY was added (1:1000) for 2 h. Plates were washed and an avidin/alkaline phosphatase conjugate (Sigma Chemical, St. Louis, MO) was added (diluted 1:4000) for 1 h. Plates were washed and p-nitrophenyl phosphate (Pierce) was added. After an incubation period, absorbance was measured at 405 nm. The interassay coefficient of variation was 18% and the intra-assay coefficient of variation was 6%.
Competitive reverse transcriptase-polymerase chain reaction (C-RT-PCR) for human metallothionein mRNA. The C-RT-PCR has been described in detail (Sullivan and Cousins 1997). Briefly, purified monocytes from each subject were homogenized in 1 mL TRIzol reagent (Gibco BRL). RNA was either immediately extracted or stored overnight at 070ЊC and extracted the next day. Concentration and purity of the RNA samples were determined by measuring the absorbance in TE buffer (10 mmol/L Tris-HCl, pH 8.0; and 50 mmol/L EDTA) at 230, 260 and 280 nm.
The following PCR primers were used: 5 ATG GAT CCC AAC AAC TGC TCC TGC G 3 (MT5 primer); and 5 AGG GCT GTC CCA ACA TCA GGC 3 (MT3 primer). The GeneAmp RNA PCR kit (Perkin Elmer Cetus, Foster City, CA) was used for PCR amplification. Reverse transcription was performed with 200 ng RNA and 300 U reverse transcriptase (Ausubel et al. 1995) . A 180 -bp competitor metallothionein cDNA was used. The MT5 and MT3 primers simultaneously amplify both the competitor cDNA and the metallothionein cDNA from each monocyte RNA sample. The known concentration of the competitor cDNA was used to establish the concentration of the metallothionein cDNA. In the longitudinal zinc supplementation study, the sandd 10, 15 and 22. When zinc supplementation was discontinued, wich ELISA showed that there was a significantly greater concentrations of the protein decreased and were not different erythrocyte metallothionein protein concentration (P õ 0.05) at d 26 and 30 from those found in the control subjects. Erythby d 8 of supplementation when compared with control values rocyte metallothionein in the control group varied over time. (Fig. 4) . Erythrocyte metallothionein levels of the zinc-suppleErythrocyte metallothionein concentrations in control submented men were also significantly greater than controls on jects at d 07 and d 0 were significantly different (P õ 0.01) from those of control subjects at d 10, 15 and 22. Monocyte metallothionein mRNA. RT-PCR showed that there were greater monocyte metallothionein mRNA levels in zinc-supplemented subjects than in controls (Fig. 5) . These mRNA levels (measured as metallothionein cDNA in picograms cDNA per nanogram of total monocyte RNA) were 2.6-fold greater (P õ 0.01) in zinc-supplemented subjects than in the control group by d 2 of supplementation. Levels remained significantly elevated in the zinc-supplemented men through d 18. The highest mRNA levels were on d 8 and 18. These were approximately threefold greater than those obtained before supplementation. They were not significantly different from the other levels of the zinc-supplemented subjects during the supplementation period, however. Monocyte metallothionein mRNA levels returned to base-line values by d 22, 4 d after supplementation was discontinued. Monocyte metallothionein mRNA levels did not vary significantly in the control subjects during the comparison period.
Plasma zinc and copper. Plasma zinc concentration was significantly (P õ 0.01) increased by 86% at d 6 of supplementation compared with control subjects (Table 1) . By d 15 of supplementation, plasma zinc had decreased compared with that at d 6, but was still significantly elevated (P õ 0.05) at 12% above the concentration found in control subjects. Plasma zinc concentrations in zinc-supplemented subjects were { SEM, n Å 9-13. Significantly different from control subjects (**P õ 0.01 or *P õ 0.05). lothionein mRNA was elevated in Zn-supplemented men man metallothionein-1 antibody for the measurement of the throughout the supplementation period, the plasma zinc conprotein in human plasma. centration was not elevated consistently during that period.
The sandwich ELISA described here uses a monoclonal This suggests that the stimulus for the elevation in monocyte antibody that does not exhibit appreciable nonspecific binding metallothionein expression is not the plasma zinc concentraand shows high specificity for human metallothionein. In addition. Perhaps the flux of zinc through a specific metabolic tion, a chicken anti-human metallothionein antibody was used pool(s) provides the stimulus because the decrease in plasma as the detection antibody. Antibodies produced in avians can zinc concentration observed in the zinc-supplemented subjects offer several important advantages over those produced in by d 15 suggests that these subjects are adapting to a high zinc mammals. Because of the phylogenetic divergence of avians intake.
and mammals, there is greater potential of producing specific There were no significant differences in plasma copper conantibodies against human proteins in chickens compared with centrations between control and zinc-supplemented subjects other mammalian species (Gassman et al. 1990 ). This is of at any time during the study (Table 1) , although there was a particular relevance for a highly conserved protein such as trend toward higher levels in both groups over time.
metallothionein (Hamer 1986, Kagi and Kojima 1987) . Assays for metallothionein protein in human studies could DISCUSSION utilize erythrocytes, leukocytes or plasma. Our data suggest that metallothionein protein levels in leukocytes are too low With the abundance of new information about the essento be measured by ELISA using the number of cells that can tiality of zinc to human health, there is a need for specific, be obtained routinely in survey studies. Specifically, we were reliable indicators of zinc status and cellular responses to diunable to detect metallothionein protein in monocytes, where etary zinc. However, several factors have made the identificathe protein is most abundant (Harley et al. 1989 , Pauwels et tion of such markers difficult. Because zinc metabolism is under al. 1994), by using the sandwich ELISA method in control tight homeostatic control, the most commonly used variables subjects or subjects who received zinc supplementation at 50 for measuring nutrient status (reviewed in Cousins 1996, Mills mg/d for 10 d. Consequently, erythrocytes have been a focus 1989) such as zinc concentrations in body fluids and zinc meof our studies on human metallothionein protein as a reflection talloenzyme activities have not been reliable for the assessment of zinc intake. Robertson et al. (1989) showed that most of of zinc status (King 1990) . Consequently, marginal zinc defithe metallothionein in the erythrocyte population of rats is ciency, which may be prevalent in several populations accounted for by the reticulocytes. Huber and Cousins (1993b) throughout the U.S. and the world (Golden 1989, Rosado et showed that the source of erythrocyte metallothionein in rats al. 1997, Sazawal et al. 1996) , is especially difficult to detect.
is the early progenitor cells from the bone marrow and that Metallothionein expression has shown promise as a poteninduction of the protein in marrow will increase via cellular tial index of zinc status in animals and humans. Blalock et al.
proliferation associated with acute blood loss and accelerated (1988) showed that metallothionein mRNA expression in rat erythropoiesis. The increases in erythrocyte metallothionein liver, intestine and kidney is regulated by zinc intake. Metalloin the control subjects of this study could be related to the thionein protein levels in rat plasma and erythrocytes have number of blood samples (a total of 12) removed from each been shown to correlate well with zinc intake (Bremner et al. subject. This number of blood draws was for the purpose of 1987, Sato et al. 1984) . By using a competitive ELISA, Grider defining the kinetics of monocyte metallothionein mRNA inet al. (1990) showed that erythrocyte metallothionein protein duction. The results presented here clearly show that zinc in humans also reflected alterations in dietary zinc. The comsupplementation at 50 mg/d increases erythrocyte metallothiopetitive ELISA was an initial effort in the search for a method nein levels. This supports the observations of Grider et al. for assessing zinc status in humans based on this zinc-inducible (1990) . Further studies are required to determine whether the protein. We showed that erythrocyte metallothionein was parsandwich ELISA is able to measure erythrocyte metallothioticularly effective as an index of severe zinc depletion (Thomas nein during zinc depletion. et al. 1992). Recently, Akintola et al. (1995) reported the development of a competitive ELISA using a rabbit anti-huAt steady state, however, metallothionein protein levels ard for helpful discussions during the design of the C-RT-PCR proceshould be proportional to metallothionein mRNA levels. 
